Literature DB >> 21789625

Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?

Yasumasa Kuroda1, Masaaki Kitada, Shohei Wakao, Mari Dezawa.   

Abstract

Adult stem cells typically generate the cell types of the tissue in which they reside, and thus the range of their differentiation is considered limited. Bone marrow mesenchymal stem cells (MSCs) are different from other somatic stem cells in that they differentiate not only into the same mesodermal-lineage such as bone, cartilage, and adipocytes but also into other lineages of ectodermal and endodermal cells. Thus, MSCs are a unique type of adult stem cells. In addition, MSCs home to damaged sites, differentiate into cells specific to the tissue and contribute to tissue repair. Therefore, application of MSCs in the treatment of various diseases, including liver dysfunction, myocardial infarction, and central nervous system repair, has been initiated. Because MSCs are generally harvested as adherent cells from bone marrow aspirates, however, they comprise heterogeneous cell populations and their wide-ranging differentiation ability and repair functions are not yet clear. Recent evidence suggests that a very small subpopulation of cells that assume a repair function with the ability to differentiate into trilineage cells resides among human MSCs and effective utilization of such cells is expected to improve the repair effect of MSCs. This review summarizes recent advances in the clarification of MSC properties and discusses future perspectives.

Entities:  

Mesh:

Year:  2011        PMID: 21789625     DOI: 10.1007/s00005-011-0139-9

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  32 in total

1.  Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells.

Authors:  Yasumasa Kuroda; Shohei Wakao; Masaaki Kitada; Toru Murakami; Makoto Nojima; Mari Dezawa
Journal:  Nat Protoc       Date:  2013-06-20       Impact factor: 13.491

2.  Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model.

Authors:  Arne Berner; Jan Henkel; Maria A Woodruff; Roland Steck; Michael Nerlich; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Stem Cells Transl Med       Date:  2015-04-01       Impact factor: 6.940

3.  Stage-specific embryonic antigen-4 is not a marker for chondrogenic and osteogenic potential in cultured chondrocytes and mesenchymal progenitor cells.

Authors:  Karsten Schrobback; Jana Wrobel; Dietmar W Hutmacher; Tim B F Woodfield; Travis J Klein
Journal:  Tissue Eng Part A       Date:  2013-02-19       Impact factor: 3.845

Review 4.  Gene therapy as a potential tool for treating neuroblastoma-a focused review.

Authors:  M D Kumar; A Dravid; A Kumar; D Sen
Journal:  Cancer Gene Ther       Date:  2016-04-15       Impact factor: 5.987

5.  Immunological effect induced by mesenchymal stem cells in a rat liver transplantation model.

Authors:  Zhenqiang Sun; Tao Li; Hao Wen; Haijiang Wang; Weizheng Ji; Yan Ma
Journal:  Exp Ther Med       Date:  2015-06-05       Impact factor: 2.447

Review 6.  Cell replacement therapy is the remedial solution for treating Parkinson's disease.

Authors:  Venkatesan Dhivya; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-06-30

7.  Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques.

Authors:  Takuya Hayashi; Shohei Wakao; Masaaki Kitada; Takayuki Ose; Hiroshi Watabe; Yasumasa Kuroda; Kanae Mitsunaga; Dai Matsuse; Taeko Shigemoto; Akihito Ito; Hironobu Ikeda; Hidenao Fukuyama; Hirotaka Onoe; Yasuhiko Tabata; Mari Dezawa
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 8.  Embryonic wound healing: a primer for engineering novel therapies for tissue repair.

Authors:  Katherine E Degen; Robert G Gourdie
Journal:  Birth Defects Res C Embryo Today       Date:  2012-09

9.  Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.

Authors:  Laura Shin; Daniel A Peterson
Journal:  Stem Cells Transl Med       Date:  2012-01-26       Impact factor: 6.940

Review 10.  Muse cells and induced pluripotent stem cell: implication of the elite model.

Authors:  Masaaki Kitada; Shohei Wakao; Mari Dezawa
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.